Kazuya SAKAI, MD, PhD

Dr.
Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk
8500, West-Vlaanderen, Belgium

Kazuya obtained a license of Medical Doctor in the Faculty of Medicine at Nara Medical University in Japan (2011). Subsequently, he was trained for five years as a hematologist at Kurashiki Central Hospital in Japan. In 2016, he started his PhD under the supervision of Prof. Dr. Masanori Matsumoto in Molecular and Regenerative Medicine at Nara Medical University which he successfully defended in 2020. He was also involved in the management of the Japanese registry data for both congenital and immune-mediated thrombotic thrombocytopenic purpura (cTTP and iTTP). His research interest focuses on studying the immune response in iTTP based on the interaction between HLA molecules and ADAMTS13 peptides.

Presentation(s):

• OC 14.6 - Thrombotic Thrombocytopenic Purpura (TTP) Treatment

  Sunday, June 25, 2023
  10:45 – 12:00 ET

• OC 42.3 - Immune-mediated TTP patients in remission with recovered ADAMTS13 activity but an open ADAMTS13 conformation are at risk for earlier ADAMTS13 relapse

  Monday, June 26, 2023
  15:15 – 15:30 ET